Resistance to Antitubercular Drugs
- 1 January 1998
- book chapter
- review article
- Published by Springer Science and Business Media LLC in Advances in experimental medicine and biology
- Vol. 456, 115-144
- https://doi.org/10.1007/978-1-4615-4897-3_7
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- A Mechanism of Drug Action Revealed by Structural Studies of Enoyl ReductaseScience, 1996
- DNA Gyrase and Topoisomerase IV on the Bacterial Chromosome: Quinolone-induced DNA CleavageJournal of Molecular Biology, 1996
- Binding of Catalase-Peroxidase-Activated Isoniazid to Wild-Type and Mutant Mycobacterium tuberculosis Enoyl-ACP ReductasesJournal of the American Chemical Society, 1996
- Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicingJournal of Molecular Biology, 1994
- Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experimentsTubercle, 1991
- Screening of natural products for antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Mutations in ribosomal proteins S4 and S12 influence the higher order structure of 16 S ribosomal RNAJournal of Molecular Biology, 1989
- The action of antituberculosis drugs in short-course chemotherapyTubercle, 1985
- Viomycin resistance: Alterations of either ribosomal subunit affect the binding of the antibiotic to the pair subunit and the entire ribosome becomes resistant to the drugBiochemical and Biophysical Research Communications, 1979
- Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds1Journal of the American Chemical Society, 1952